Inflammatory biomarker, neopterin, enlarges splenic mast-cell-progenitor pool: Prominent impairment of responses in age-related stromal cell-impairment mouse SCI/SAM
Introduction
Neopterin is a metabolite of guanosine triphosphate that is produced in the biopterin synthetic pathway [1]. This metabolite is generated in large amounts by monocytes and macrophages in response to interferon-γ (IFN-γ) [2]. An increased neopterin production is observed following infection by viruses, bacteria and parasites [3]. Because neopterin level in body fluid reflects immune responses in vivo, neopterin is regarded as a sensitive marker of the activation of the cellular immune system in humans as well as a factor for prognosis and its indicator biomarker [3], [4]. However, there is evidence that neopterin is not only a marker of the activity of the immune system, but it also exerts distinct biological effects; that is, neopterin induces the apoptosis of L2 rat alveolar epithelial cells [5], and inhibits NADPH-oxidase in peritoneal macrophages [6]. Neopterin has also been found to inhibit erythropoietin gene expression [7], induce the expression of genes for the proto-oncogene c-fos [8], and activate the transcription of nuclear factor-kappa B (NF-κB) [9]. Furthermore, because the expression of the inducible nitric oxide synthase (iNOS) gene and the subsequent release of nitric oxide (NO) from vascular smooth muscle cells (VSMCs) following incubation with neopterin are documented, neopterin is supposed to play the role of a modulator in Gram-negative-bacterium-induced endotoxemia that contributes to the overproduction of NO [10], [11]. Neopterin, on the other hand, augments the colony formation of granulocyte–macrophage progenitor cells (CFU-GM) in a semisolid culture system [12] and that the intraperitoneal injection of neopterin into mice stimulates granulopoiesis [13]. This stimulation of in vitro and in vivo granulopoiesis is due not to a direct effect of neopterin on hematopoietic stem cells, but rather to an indirect effect of stromal-cell-mediated hematopoietic growth factors, such as GM-CSF and IL-6 [12]. In contrast to the enhancement of granulopoiesis by neopterin, neopterin suppresses in vitro and in vivo B-lymphopoiesis by inducing the production of predominantly negative regulators by stromal cells, such as TNF-α and IL-6 (Minami et al., in press).1 These findings indicate that neopterin is biologically active against hematopoiesis during inflammatory processes, which is induced by stimulating the production of cytokines by stromal cells.
Mast cells are derived from hematopoietic stem cells, but they do not ordinarily circulate in the mature form; instead, they undergo differentiation and maturation in the mucosal settlement after the migration of their precursors into vascularized tissues or serosal cavities in which they will ultimately reside [14], [15], [16], [17], [18]. The physiologic functions of mast cells include the enhancement of inflammatory responses induced by parasites and bacterial infection and immune complexes [19], [20], [21]. Because neopterin facilitates splenic immune responses, it is of interest to determine whether neopterin affects mast-cell progenitor cells (CFU-mast) in hematopoietic tissues, specifically in the spleen, during inflammatory processes.
SAM/P-1, a subline of senescence-accelerated mice (SAM) exhibiting a unique stromal cell impairment after 30 weeks of age, was used because the numbers of splenic cells and splenic hematopoietic progenitor cells start to decrease thereafter [22], [23], [24], [25]. Therefore, stromal cell impairment (SCI) mice, SAM/P-1, are a useful tool for elucidating the possible interaction between neopterin and stromal cells during mast cell development. In this study using a stromal impairment (SCI) mouse, SAM/P-1, we investigated whether neopterin affects the pool of CFU-mast in hematopoietic tissues.
Section snippets
Mice
A subline of SAM, SAM/P-1 [22], which is a senescent stromal impairment substrain (SCI mouse), was derived from an AKR/J mouse (Jackson Laboratory, Bar Harbor, ME), and established by Dr. Toshio Takeda, Professor Emeritus of the Chest Disease Research Institute, Kyoto University, Japan. The mice were bred and maintained in an experimental facility at the National Institute of Health Sciences under pathogen-free conditions. SAM/P-1 exhibits stromal cell impairment after 30–36 weeks of age. In
Effects of neopterin on CFU-mast colony formation in vitro in unfractionated BMCs and Lin(−) BMCs
To determine whether neopterin directly affects the proliferation or differentiation of mast cell progenitors (CFU-mast), we cultured unfractionated BMCs from young non-SCI and senescent SCI mice in a soft agar culture medium containing IL-3 and neopterin at various concentrations, and measured the number of colonies formed (Fig. 1A, left). In colonization assays without neopterin, the absolute numbers of colonies from the non-SCI and SCI mice were 172.5 ± 6.8 and 43.8 ± 4.0 per 1 × 105 cells,
Discussion
Mast cells are ubiquitously distributed in most tissues throughout the body and are among the major effector cells in inflammatory reactions. The increase in mast cell number in tissues can occur during host responses to infection by the enhancement of their recruitment and/or retention, and local maturation of mast cell progenitor cells derived from hematopoietic stem cells [14], [15], [16], [17], [18], [19], [20], [21]. Neopterin production increases in protracted bacterial infection. Highest
Acknowledgements
We thank Dr. Yukio Kodama, Ms. Erika Tachihara and Ms. Minako Kenjoh for assistance in maintaining the SCI mice in the experimental animal facilities, and Ms. Sonoko Araki and Ms. Sachiko Yuda for technical assistance. This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for the promotion of industry–university collaboration at Nihon University and also by a Nihon University Joint Research Grant for 2004.
References (47)
- et al.
Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2
FEBS Lett
(1996) - et al.
Inhibitory effect of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages
FEBS Lett
(1993) - et al.
Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells
FEBS Lett
(1996) - et al.
Neopterin derivatives together with cyclic guanosine monophosphate induce c-fos gene expression
FEBS Lett
(1994) - et al.
Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells
FEBS Lett
(1995) - et al.
Mast cell in the front line. Innate immunity
Curr Biol
(1996) - et al.
A new murine model of accelerated senescence
Mech Ageing Dev
(1981) - et al.
Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice
Mech Ageing Dev
(1990) - et al.
Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation
Exp Hematol
(2004) - et al.
Physiopathological studies on granulocyte–macrophage colony stimulating factor and multi-colony stimulating factor producing leukemia L8313 induced by irradiation of C3H mice
Leuk Res
(1986)
Streptococcal erythrogenic toxins induce neopterin formation in human peripheral blood mononuclear cells but not in the human myelomonocytoma cell line THP-1
Immunobiology
Streptococcal erythrogenic toxins induce neopterin formation in human peripheral blood mononuclear cells but not in the human myelomonocytoma cell line THP-1
Immunobiology
Biochemistry of the pteridines
Angew Chem Int Ed Engl
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma
J Exp Med
Neopterin as a marker for immune system activation
Curr Drug Metab
Potential role of immune system activation – associated production on neopterin derivates in human
Inflamm Res
Neopterin-induced suppression of erythropoietin production in vitro
Pteridines
Nitric oxide and shock
Dis Mon
Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal cell function
Hematol Oncol
In vivo stimulatory effects of neopterin on hematopoiesis
Pteridines
Heterogeneity of mast cell and phenotypic change between subpopulations
Annu Rev Immunol
Mast cell
Physiol Rev
Regulation of mast-cell and basophil function and survival by Ig-E
Nat Rev Immunol
Cited by (8)
The relation between oxidative stress, inflammation, and neopterin in the paraquat-induced lung toxicity
2015, Human and Experimental ToxicologyAge-related molecular aspects of immunomodulating activity of peptides in the spleen
2014, Advances in GerontologyAge-related decline of mast cell regeneration in senescence-accelerated mice (SAMP1) after chemical myeloablation due to senescent stromal cell impairment
2012, Experimental Biology and MedicineNeopterin, inflammation-associated product, prolongs erythropoiesis suppression in aged SAMP1 mice due to senescent stromal-cell impairment
2012, Experimental Biology and Medicine